Department of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.
University of Cambridge, MRC Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 7HB, U.K.
Anal Chem. 2020 Dec 15;92(24):15781-15788. doi: 10.1021/acs.analchem.0c02823. Epub 2020 Nov 25.
Protein-protein interactions (PPIs) are an essential part of correct cellular functionality, making them increasingly interesting drug targets. While Förster resonance energy transfer-based methods have traditionally been widely used for PPI studies, label-free techniques have recently drawn significant attention. These methods are ideal for studying PPIs, most importantly as there is no need for labeling of either interaction partner, reducing potential interferences and overall costs. Already, several different label-free methods are available, such as differential scanning calorimetry and surface plasmon resonance, but these biophysical methods suffer from low to medium throughput, which reduces suitability for high-throughput screening (HTS) of PPI inhibitors. Differential scanning fluorimetry, utilizing external fluorescent probes, is an HTS compatible technique, but high protein concentration is needed for experiments. To improve the current concepts, we have developed a method based on time-resolved luminescence, enabling PPI monitoring even at low nanomolar protein concentrations. This method, called the protein probe technique, is based on a peptide conjugated with Eu chelate, and it has already been applied to monitor protein structural changes and small molecule interactions at elevated temperatures. Here, the applicability of the protein probe technique was demonstrated by monitoring single-protein pairing and multiprotein complexes at room and elevated temperatures. The concept functionality was proven by using both artificial and multiple natural protein pairs, such as KRAS and eIF4A together with their binding partners, and C-reactive protein in a complex with its antibody.
蛋白质-蛋白质相互作用 (PPIs) 是正确细胞功能的重要组成部分,因此它们成为越来越有趣的药物靶点。虽然基于Förster 共振能量转移的方法传统上被广泛用于 PPI 研究,但无标记技术最近引起了广泛关注。这些方法非常适合研究 PPI,最重要的是,由于无需标记相互作用的任何一方,因此可以减少潜在的干扰和总体成本。已经有几种不同的无标记方法可用,例如差示扫描量热法和表面等离子体共振,但这些生物物理方法的通量低至中等,这降低了它们在 PPI 抑制剂高通量筛选 (HTS) 中的适用性。利用外部荧光探针的差示扫描荧光法是一种与 HTS 兼容的技术,但实验需要高浓度的蛋白质。为了改进当前的概念,我们开发了一种基于时间分辨发光的方法,即使在低纳摩尔蛋白质浓度下也能监测 PPI。这种方法称为蛋白质探针技术,它基于与 Eu 螯合物偶联的肽,并且已经被用于监测在高温下的蛋白质结构变化和小分子相互作用。在这里,通过在室温及高温下监测单蛋白对和多蛋白复合物,证明了蛋白质探针技术的适用性。通过使用人工和多个天然蛋白质对(例如 KRAS 和 eIF4A 及其结合伴侣)以及 CRP 在与抗体形成复合物的情况下,证明了该概念的功能。